Bobby Wilkerson
Hematology & Oncology · Jackson, MSNPI 1245212844
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $982 and has fallen 93.2% since, to $66 in 2022. That places this record below the midpoint for hematology & oncology clinicians in MS, where the typical reported total is $9,632.
Across 141 payments — averaging $13.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$225
- Merck$221
- Novartis$196
- Johnson & Johnson$191
- Genentech USA, Inc.$138
- Astellas Pharma US Inc$114
- plus $883 from 28 others
Across 34 payments — averaging $763.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$22K
- Pharmacyclics LLC, An Abbvie Company$4K
What the payments were for
- Food & beverage$1,87896%
- Education$884%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $225 |
| Merck | 19 | $221 |
| Novartis | 14 | $196 |
| Johnson & Johnson(2 entities) | 14 | $191 |
| Genentech USA, Inc. | 10 | $138 |
| Astellas Pharma US Inc | 7 | $114 |
| E.r. Squibb & Sons, L.L.C. | 8 | $104 |
| Sanofi-aventis U.S. LLC | 4 | $86 |
| Sanofi | 5 | $82 |
| Puma Biotechnology, Inc. | 6 | $79 |
| AstraZeneca | 5 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $38 |
| Seagen Inc. | 3 | $36 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Gilead(2 entities) | 2 | $26 |
| Rigel Pharmaceuticals, Inc. | 2 | $26 |
| Eisai Inc. | 1 | $25 |
| GSK | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Acceleron Pharma, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Beigene USA, Inc. | 1 | $14 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Dova Pharmaceuticals | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
| Secura Bio, Inc. | 1 | $12 |
| Epizyme, Inc. | 1 | $12 |
| AbbVie | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
| Kyowa Kirin, Inc. | 1 | $11 |
How this compares
$1,966 in reported general payments places this provider in the 10th percentile of 57 hematology & oncology providers in Mississippi.
Other hematology & oncology in Jackson
- Carter MilnerJackson$248K
- Guangzhi QuJackson$59K
- John HeneganJackson$35K
- Barbara CraftJackson$11K
- Grace ShumakerJackson$7K
- Justin BakerJackson$3K
- Katherine ThielJackson$2K
- Solly ChedidPascagoula$1.7M
- Jennifer EubanksMeridian$44K
- Daniel PattersonPascagoula$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.